Mercury exposure makes that struggle worse, potentially accelerating plaque buildup
In the Amazon and other mercury-laden regions of Brazil, a quiet metabolic threat has long gone unrecognized alongside the more visible neurological damage of heavy metal poisoning. Researchers at the Federal University of Ceará, working with colleagues in Bristol and California, have found that mercury disrupts the body's management of cholesterol and fat — and that this disruption falls hardest on those whose genetics already leave them less equipped to handle it. The discovery reframes mercury contamination not merely as a neurological crisis but as a cardiovascular one, and it asks us to consider how the burdens of environmental harm are never distributed equally.
- Mercury contamination in Brazil's Amazon is not an isolated industrial accident but a chronic, widespread condition affecting entire communities over generations.
- New research reveals mercury damages fat metabolism and elevates cholesterol and triglycerides — risks that compound dangerously for people with ApoE protein deficiencies.
- Computational modeling of human genetic variants suggests carriers of the ApoE4 gene may be doubly exposed: unable to neutralize mercury neurologically or metabolically.
- The gap between what science has assumed about mercury's harm and what it actually does to the cardiovascular system is now measurably wider — and the stakes are higher.
- Researchers are moving toward nutritional interventions to protect genetically vulnerable populations in contaminated regions, where exposure is often unavoidable.
Scientists at Brazil's Federal University of Ceará have found that toxic mercury exposure damages the body's ability to manage cholesterol and fat metabolism — a threat that compounds existing cardiovascular risk, particularly for people with certain genetic profiles. The research, published in Chemical Research in Toxicology and born from a doctoral thesis by Synara Lopes, brought together universities in Brazil, the United Kingdom, and the United States, combining animal experiments with molecular computer simulations.
Mice exposed to methylmercury — the element's most toxic form — in their drinking water for twenty days showed elevated cholesterol and triglyceride levels, fatty liver accumulation, and structural changes to fat tissue. Those lacking functional ApoE protein, which the body uses to transport and process fats, suffered far greater damage than those with normal ApoE function. The implication is significant: people whose bodies already struggle to manage lipids face a compounded risk when exposed to mercury, potentially accelerating arterial plaque buildup and heart disease.
Because mice do not carry the same ApoE genetic variants as humans, the team used computational modeling to simulate how three human versions — ApoE2, ApoE3, and ApoE4 — interact with methylmercury at the molecular level. ApoE2 and ApoE3 bound tightly to mercury, suggesting some capacity to sequester it. ApoE4 showed no stable binding, raising the hypothesis that carriers of this variant — already known to face higher neurological risk from mercury — may also be unable to clear it metabolically.
Professor Reinaldo Oriá, who directed the research, stressed the public health dimension: for communities living with chronic mercury exposure in contaminated regions, the threat now appears to extend well beyond neurological symptoms. The team plans to develop nutritional interventions for vulnerable populations and to continue exploring mercury's broader neuroendocrine effects through ongoing international collaboration.
Scientists at Brazil's Federal University of Ceará have discovered that toxic mercury exposure damages not just the brain and kidneys, as long known, but also the body's ability to manage cholesterol and fat metabolism—with some people far more vulnerable than others based on their genetics.
The research, published this month in Chemical Research in Toxicology, emerged from a doctoral thesis by Synara Lopes and represents a collaboration between three universities: Ceará in Brazil, Bristol in the United Kingdom, and California in the United States. The work combined animal experiments with computer simulations to understand how a protein called Apolipoprotein E (ApoE) influences whether mercury poisoning damages metabolic health. The findings matter because mercury contamination is endemic in the Amazon and other Brazilian regions, and the new evidence suggests it poses a cardiovascular threat beyond what was previously understood.
The research team exposed mice to methylmercury—the most toxic form of the element—in drinking water for twenty days. Those lacking functional ApoE protein, a molecule essential for transporting and processing fats in the body, showed dramatically elevated cholesterol and triglyceride levels, along with fatty accumulation in the liver and structural changes to fat tissue. The animals with normal ApoE protein showed mercury exposure too, but the damage was less severe. This suggested that people with ApoE deficiencies face compounded risk: their bodies already struggle to manage lipids, and mercury exposure makes that struggle worse, potentially accelerating plaque buildup in arteries and increasing the likelihood of heart disease.
Because mice don't carry the same genetic variants of ApoE that humans do, the team turned to computational modeling. They simulated how three human versions of the protein—ApoE2, ApoE3, and ApoE4—interact with methylmercury at the molecular level. Two variants, ApoE2 and ApoE3, bound tightly to mercury, suggesting the body could at least sequester it. ApoE4, however, showed no stable binding. This matters because people carrying the APOE4 gene already face higher risk of mercury's neurological damage. The new finding raises a hypothesis: ApoE4 may also fail to clear mercury from the body efficiently, compounding metabolic harm on top of brain damage.
Professor Reinaldo Oriá, who directed the work through the Scarring Biology, Ontogeny and Tissue Nutrition Laboratory at Ceará, emphasized the public health dimension. Mercury poisoning is not a rare industrial accident in Brazil—it is a chronic, widespread problem in certain regions. The research suggests that for people living in contaminated areas, especially those carrying genetic vulnerabilities, the threat extends beyond neurological symptoms to cardiovascular disease. The team plans to pursue nutritional interventions designed to protect these vulnerable populations, and to deepen understanding of mercury's neuroendocrine effects through continued international collaboration. The work opens a door to prevention strategies that might reduce harm in communities where mercury exposure is unavoidable.
Citações Notáveis
Mercury poisoning is endemic in Amazon regions and other Brazilian areas, and our findings indicate methylmercury may worsen metabolic disorders, raising cardiovascular disease risk in vulnerable populations.— Professor Reinaldo Oriá, Federal University of Ceará
People carrying the APOE4 gene already face higher neurological risk from mercury. We need to investigate whether they also struggle to clear it from their bodies, compounding the damage.— Professor Reinaldo Oriá
A Conversa do Hearth Outra perspectiva sobre a história
Why does the ApoE protein matter so much here? It seems like just one protein among thousands.
Because it's the gatekeeper for how your body handles fats. Without it working properly, cholesterol and triglycerides pile up. Mercury exposure makes that worse—it's like adding weight to someone already struggling to carry a load.
So the mice without ApoE got sicker from mercury than the normal mice?
Much sicker. The ones with normal ApoE could at least partially handle the mercury. The ones without it showed severe metabolic damage—elevated lipids, fatty liver, changes to fat tissue itself.
And then you found that some human genetic variants of ApoE don't bind to mercury at all?
Right. ApoE4 showed no stable binding in our computer models. That's concerning because people with ApoE4 already have higher neurological risk from mercury. If they also can't clear it from their bodies, the damage compounds.
Is this proven in humans yet?
No. We've shown it in mice and modeled it computationally. The next step is testing whether this mechanism actually holds in human populations. We have epidemiological evidence that ApoE4 carriers are more vulnerable to mercury's brain effects, but we need to investigate whether the metabolic pathway works the way we think it does.
Where does this matter most?
The Amazon and other regions where mercury contamination is endemic. People there are exposed chronically, often through contaminated fish. If they also carry ApoE4, they face both neurological and cardiovascular risk from the same exposure.
What's the practical next step?
We want to develop nutritional interventions—ways to protect people who can't avoid the exposure. That means understanding the mechanism deeply enough to intervene before damage accumulates.